Gartnavel General Hospital is a teaching hospital in the West End of Glasgow, Scotland. The hospital is located next to the Great Western Road, between Hyndland, Anniesland and Kelvindale. Hyndland railway station is adjacent to the hospital.

There are 668 beds in Gartnavel General Hospital.

During the past decade, Gartnavel General Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gartnavel General Hospital" #1 sponsor was "NHS Greater Glasgow and Clyde" with 6 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored, "Abbott" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "Genzyme, a Sanofi Company" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gartnavel General Hospital" #1 collaborator was "University of Glasgow" with 4 trials as a collaborator, "Medical Research Council" with 3 trials as a collaborator, "Queen's University, Belfast" with 2 trials as a collaborator, "Asthma Allergy & Inflammation Research Trust" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Gartnavel General Hospital" are "Asthma" (7 trials), "Chronic Hepatitis" (2 trials), "Fallopian Tube Cancer" (2 trials), "Hepatitis B" (2 trials) and "Hepatitis B, Chronic" (2 trials). Many other conditions were trialed in "Gartnavel General Hospital" in a lesser frequency.

Most popular intervention types in "Gartnavel General Hospital" are "Drug" (28 trials), "Other" (7 trials), "Procedure" (6 trials), "Biological" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Adefovir" (2 trials), "Atrasentan" (2 trials), "Clevudine" (2 trials) and "JNJ-56136379" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gartnavel General Hospital" are 39 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Gartnavel General Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Gartnavel General Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Gartnavel General Hospital, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".